Pharmacy Management
Prescription drugs are the fastest growing component of healthcare costs. These costs can be prohibitive, requiring employers to change plan designs and shift even more cost to their employees. This is particularly true for specialty medications that typically represent 50% of drug spend from just 1-2% of drug utilizers.
Unfortunately, many employers don’t have the purchasing power or market leverage to negotiate better pricing. It’s also challenging for employers to identify and access money saving opportunities.
Our Alera Group Pharmacy Solutions practice has a dedicated team of experienced, in-house Pharmacy Benefits Management experts. They offer a full range of pharmacy consulting services, including:
- Prescription drug program evaluations for clients of all sizes and industries
- Comprehensive RFP management renewal, market check and RFI
- PBM contract review and negotiation
- Consultative support to identify and deploy unique cost-mitigation for specialty drug solutions
- Data analytics that enable precise financial and clinical pharmacy benefits consulting and reporting, maximizing the plan value and employee dollars
- All forms of pharmacy benefits auditing, including PBM contract pricing, plan design and clinical
- On-going risk management and cost containment under our Rx Concierge Program
With Alera Group, you have a local partner and a team of experts you can rely on to help you manage pharmacy costs and improve your outcomes today and in the future.
Our Alera Group Pharmacy Solutions experts are backed by leading-edge tools and strategic solutions focused on meeting the needs and expectations of our clients through every stage of the pharmacy process.
Control pharmacy costs
From procurement to prescriptions.
EXPERT EDUCATION
Events and Webinars
Employee Benefits
Driving Communications and Engagement: Open Enrollment
Our experts will walk you through a strategic planning process to make sure you’re sharing in a way that not only drives employee awareness and engagement but also reaches your workforce across platforms with what they need to know about choosing the right benefits for them and their families.
August 15, 2024 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Q3 Compliance Update
Alera Group's quarterly employee benefits compliance roundup will help you stay current on the latest national regulatory developments impacting employers.
September 3, 2024 at 01:00 pm CT | Virtual
Sign Up
Employee Benefits
Is Tech-Enabled Brokerage Right for You?
Our experts will lay out what tech-enabled brokerage is, how it works and why it makes sense for the right organizations.
September 19, 2024 at 01:00 pm CT | Virtual
Sign Up
THOUGHT LEADERSHIP
Insights
Employee Benefits
Benefits Benchmarking Webinar: What To Do With the Data
If you’re designing your company’s employee benefits program, you want to know what your peers and competitors are offering. Employee retention and talent acquisition are largely dependent on whether you offer a benefits package that meets or exceeds the standards of your industry, location and company size while managing costs in an increasingly expensive market for healthcare and pharmaceuticals. That’s why Alera Group places a high priority on using benchmarking data and analysis to inform and otherwise serve our clients.
July 1, 2024
Find out more
Employee Benefits
How To Lower Healthcare Costs While Improving Benefit Offerings
Join us on June 20 for a one-hour webinar designed to help you eliminate wasteful healthcare spending while providing your employees with benefits that attract and retain talent. We’ll take you through our three-step solution.
June 11, 2024
Find out more Employee Benefits
Legal Alert: RxDC Reporting Due June 1
Reminder: RxDC Reporting Due June 1
With the 2023 reference year RxDC reporting deadline approaching soon, plan sponsors should familiarize themselves with recent updates to the RxDC Reporting Instructions.
March 27, 2024
Find out more Employee Benefits
Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group
Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.
February 6, 2024
Find out more